CSTL peer analysis
Castle Biosciences (CSTL) against its competitors: price, today's move, 1-year return and market value side by side.
CSTL and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| BDSX Biodesix | $23.25 | -5.93% | 253.96% | – |
| BIAF bioAffinity | $2.98 | 2.41% | -91.86% | – |
| FRNM Freenome | $12.48 | -2.95% | – | – |
| GH Guardant Health | $170.73 | -4.51% | 84.75% | $23.99B |
| MDXH MDxHealth | $0.16 | -9.88% | -96.65% | – |
| MYGN Myriad Genetics | $5.86 | -7.72% | -26.29% | $607.38M |
| NEO NeoGenomics | $16.57 | -4.63% | 71.05% | $2.25B |
| PSNL Personalis | $15.82 | 0.00% | 66.35% | $1.69B |
| VCYT Veracyte | $49.31 | -1.40% | 39.57% | $4.02B |
| CSTL Castle Biosciences | $34.75 | -6.49% | 43.54% | $1.14B |
- CSTL's peers: BDSX (Biodesix), BIAF (bioAffinity), FRNM (Freenome), GH (Guardant Health), MDXH (MDxHealth), MYGN (Myriad Genetics), NEO (NeoGenomics), PSNL (Personalis).
Updated 2026-11-02 19:11 UTC